Cargando…
Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States
IMPORTANCE: Genomic screening for hereditary breast and ovarian cancer (HBOC) in unselected women offers an opportunity to prevent cancer morbidity and mortality, but the potential clinical impact and cost-effectiveness of such screening have not been well studied. OBJECTIVE: To estimate the lifetim...
Autores principales: | Guzauskas, Gregory F., Garbett, Shawn, Zhou, Zilu, Spencer, Scott J., Smith, Hadley S., Hao, Jing, Hassen, Dina, Snyder, Susan R., Graves, John A., Peterson, Josh F., Williams, Marc S., Veenstra, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596578/ https://www.ncbi.nlm.nih.gov/pubmed/33119106 http://dx.doi.org/10.1001/jamanetworkopen.2020.22874 |
Ejemplares similares
-
Cost-effectiveness of obinutuzumab versus rituximab biosimilars for previously untreated follicular lymphoma
por: Spencer, Scott J, et al.
Publicado: (2021) -
Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis
por: Serbin, Michael A., et al.
Publicado: (2016) -
A Decision-Theoretic Approach to Panel-Based, Preemptive
Genotyping
por: Shi, Yaping, et al.
Publicado: (2019) -
Risk–Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults
por: Guzauskas, Gregory F., et al.
Publicado: (2017) -
Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk Reduction
por: Jones, Laney K., et al.
Publicado: (2022)